| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/01/2009 | CN101397331A Enzyme inhibitors, preparation method and use thereof |
| 04/01/2009 | CN101397317A Novel nitric acid esters steroidal compounds |
| 04/01/2009 | CN101397304A Method for preparing high-purity cefpirome sulfate by sodium salt precipitation method |
| 04/01/2009 | CN101397297A Aminothiazole derivates, preparation method and use thereof |
| 04/01/2009 | CN101397276A Dibenzimidazole and onium compound thereof, preparation method and medical use thereof |
| 04/01/2009 | CN101396557A Preparation method of combined attenuated live vaccine of measles, parotitis and rubella |
| 04/01/2009 | CN101396554A Use of recombined human interferon gamma in preparing antiviral medicine |
| 04/01/2009 | CN101396549A Oral liquid for treating emesia type diarrhea |
| 04/01/2009 | CN101396546A Preparation method of kudzu root decoction |
| 04/01/2009 | CN101396537A Chinese patent medicine capable of dredging collateral |
| 04/01/2009 | CN101396514A Traditional Chinese medicine formulation for treating Asia (Africa) chicken pest |
| 04/01/2009 | CN101396509A Chinese veterinary drug for treating livestock and poultry intestinal tract disease |
| 04/01/2009 | CN101396508A Preparation method of traditional Chinese medicine for treating acute lymphadenitis |
| 04/01/2009 | CN101396507A Traditional Chinese medicine antibacterial liquid and preparation method and use thereof |
| 04/01/2009 | CN101396485A Traditional Chinese medicine formulation for treating sucking pig yellow and white scours |
| 04/01/2009 | CN101396478A Preparation method of medicine for controlling chicken pest and red and white scours |
| 04/01/2009 | CN101396463A Chinese herbal medicine external liniment for treating beriberi |
| 04/01/2009 | CN101396452A Cold prevention medicine |
| 04/01/2009 | CN101396440A Preparation method of skin tinea treating medicine |
| 04/01/2009 | CN101396427A Traditional Chinese medicine oral liquid for treating poultry virus hepatitis and hepatic injury |
| 04/01/2009 | CN101396420A Extraction method of traditional Chinese medicine with antibiotic effect and use thereof in livestock and poultry |
| 04/01/2009 | CN101396383A Composite isatis root soft capsule and preparation method thereof |
| 04/01/2009 | CN101396382A Composite isatis root orally disintegrating tablet and preparation method thereof |
| 04/01/2009 | CN101396373A Cinobufacini extract and preparation method thereof |
| 04/01/2009 | CN101396371A Quality control method of Tibet crude-medicine processing material and new use thereof |
| 04/01/2009 | CN101396363A Composite antibacterial drugs composition containing abafungin |
| 04/01/2009 | CN101396360A Medicine lotion for treating skin or scalp superficial part mycotic infection and preparation method thereof |
| 04/01/2009 | CN101396344A Paeonol microemulsion preparation and preparation method thereof |
| 04/01/2009 | CN101396070A Veterinary traditional Chinese medicine for treating livestock and poultry pullorum disease and preparation method thereof |
| 04/01/2009 | CN100473987C Quality control method for Chinese medicine composition preparation for treating children's cold |
| 04/01/2009 | CN100473721C Pneumovirus NS proteins antagonising interferon (IFN) response |
| 04/01/2009 | CN100473644C 9-substituted minocycline compounds |
| 04/01/2009 | CN100473407C Chinese medical preparation for curing common cold and cough and preparation method thereof |
| 04/01/2009 | CN100473399C Compound wurenchun capsule fortreating organizing and chronic hepatitis |
| 04/01/2009 | CN100473398C Chinese medicine preparation for treating respiratory tract infection and virus flu, preparing method thereof |
| 04/01/2009 | CN100473393C Lonicera and scutellaria drip pill and preparation method thereof |
| 04/01/2009 | CN100473380C Medicine for treating tinea pedis |
| 04/01/2009 | CN100473377C Process for producing soft gelatin capsule |
| 03/31/2009 | US7511145 Bicyclic heteroaryl derivatives |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511136 Anticancer agents; antiproliferative agents; Alzheimer's disease; viricides; autoimmune diseases; central nervous system disorders |
| 03/31/2009 | US7511122 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions |
| 03/31/2009 | US7511121 Polymeric immunoglobulin fusion proteins that target low-affinity Fcγreceptors |
| 03/31/2009 | US7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/31/2009 | US7511061 Triazoles as farnesyl transferase inhibitors |
| 03/31/2009 | US7511047 Kinase inhibitors |
| 03/31/2009 | US7511037 N-[[4-fluoro-2-(5-methy-1H-1,2,4-triazol-1-yl)phenyl]methyl]-4-,6,7,9-tetrahydro-3-hydroxy-9,9-dimethyl-4-oxo-pyrimido[2,1-c][1,4]oxazine-2-carboxamide as an HIV integrase inhibitor |
| 03/31/2009 | US7511032 Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
| 03/31/2009 | US7511027 Administering a nucleoside or a nucleoside analog, such as (5'-fluoro-5-methyl-beta-arabinofuranosyl-uridine) or salt or prodrug that suppresses the expression of hepatitis B surface or preS1 antigen in the host 100-fold |
| 03/31/2009 | US7511024 Factor VII or VIIA-like molecules |
| 03/31/2009 | US7510853 Exhibiting similarity to cytokine; isolated or recombinant polynucleotide encoding antigenic polypeptide of sequence 2 |
| 03/31/2009 | US7510825 Detecting perturbations and alterations of the normal organization of the cell plasma membrane (PNOM)-cells within a population of cells using a "perturbed membrane-binding compound" (PMBC) of given formula; e.g. monitoring aggressiveness of a tumor |
| 03/31/2009 | US7510717 Non-toxic mutants of pathogenic gram-negative bacteria |
| 03/31/2009 | US7510702 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 03/31/2009 | CA2441313C New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 03/31/2009 | CA2396734C Extraction of flavonoids |
| 03/31/2009 | CA2210139C Immunogenic conjugate molecules |
| 03/31/2009 | CA2193597C Otic microbial combinations |
| 03/26/2009 | WO2009039135A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 03/26/2009 | WO2009039134A1 Anti-infective pyrimidines and uses thereof |
| 03/26/2009 | WO2009039127A1 Uracil or thymine derivative for treating hepatitis c |
| 03/26/2009 | WO2009038663A1 Method of treating hepatitis c patients |
| 03/26/2009 | WO2009038605A2 Flexible, polyvalent antiviral dendridic conjugates for the treatment of hiv/aids and enveloped viral infection |
| 03/26/2009 | WO2009038008A1 Process for producing fine particles and the fine particles |
| 03/26/2009 | WO2009037592A2 Triazole-based aminoglycoside-peptide conjugates and methods of use |
| 03/26/2009 | WO2009037538A2 Process for the preparation of lamivudine form i |
| 03/26/2009 | WO2009037503A2 New combination - 012 for the treatment of respiratory diseases |
| 03/26/2009 | WO2009037449A1 Solid pharmaceutical compositions comprising one or more herpes virus inhibitors and one or more reverse transcriptase inhibitors |
| 03/26/2009 | WO2009037362A1 Compositions comprising siraitia grosvenori extracts and methods for the treatment of infection |
| 03/26/2009 | WO2009037357A1 Benzimidazole nf- kappab inhibitors |
| 03/26/2009 | WO2009037264A2 Colonic delivery of antimicrobial agents |
| 03/26/2009 | WO2009037168A1 Heterocyclic antiviral compounds |
| 03/26/2009 | WO2009036590A1 Compounds isolated from antrodia cinnamomea and use thereof |
| 03/26/2009 | WO2009036568A1 Methods and compositions for treating tumors and viral infections |
| 03/26/2009 | WO2009036510A1 Novel avian cytokines and genetic sequences encoding same |
| 03/26/2009 | WO2009005870A3 Products for prophylaxis and/or treatment of viral diseases and method of making and using same |
| 03/26/2009 | WO2008139288A3 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
| 03/26/2009 | WO2008137780A3 Use of [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases |
| 03/26/2009 | WO2008118879A3 Antiviral compositions comprising 2 compounds |
| 03/26/2009 | WO2008116641A3 Oleyl phosphocholine |
| 03/26/2009 | WO2008106058A3 Inhibitors of serine proteases |
| 03/26/2009 | WO2008058897A3 Diphyllin and other lignans as a medicament for v-atpase mediated disease |
| 03/26/2009 | US20090082429 Antimicrobial Compositions and Methods of Use |
| 03/26/2009 | US20090082428 Spiroketals |
| 03/26/2009 | US20090082424 Small molecule antagonists of bcl-2 family proteins |
| 03/26/2009 | US20090082414 Deuterium-enriched viramidine |
| 03/26/2009 | US20090082403 Pyridine derivatives substituted by heterocyclic ring and phosphonoamino group, and anti-fungal agent containing same |
| 03/26/2009 | US20090082366 Hepatitis C treatment; deuterated telaprevir (VX-950) |
| 03/26/2009 | US20090082363 Deuterium-enriched posaconazole |
| 03/26/2009 | US20090082345 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors |
| 03/26/2009 | US20090082343 1,3-benzothiazinone derivatives and use thereof |
| 03/26/2009 | US20090082337 Compositions Comprising Quinolone and Methods for Treating or Controlling Infections |
| 03/26/2009 | US20090082332 Purine derivatives for the treatment of viral or allergic diseases and cancers |
| 03/26/2009 | US20090082327 Deuterium-enriched meropenem |
| 03/26/2009 | US20090082326 Soluble dosage forms containing cephem derivatives suitable for parenteral administration |
| 03/26/2009 | US20090082325 Cefidinir Oral Suspension |
| 03/26/2009 | US20090082307 Culturing Lac Z-Y+ E. coli cell on glycerol and glucose in presence of lactose as exogenous precursor and isopropyl beta -D-thiogalactoside as inducer under conditions inducing the internalization according to a mechanism of active transport of exogenous precursor by cell and production of lactose |
| 03/26/2009 | US20090082306 Deuterium-enriched telbivudine |
| 03/26/2009 | US20090082296 Mycobacterial antigens expressed during latency |
| 03/26/2009 | US20090082287 Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |